![Brian Imszennik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Brian Imszennik worked as a Senior Financial Analyst at Johnson & Johnson from 2011 to 2015 and as a Finance Manager at Janssen Pharmaceuticals, Inc. from 2015 to 2019.
He received his undergraduate degree from Lebow College of Business in 2009.
Anciens postes connus de Brian Imszennik
Sociétés | Poste | Fin |
---|---|---|
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01/02/2019 |
JOHNSON & JOHNSON | Analyste en capital-investissement | 01/03/2015 |
Formation de Brian Imszennik
Lebow College of Business | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Entreprise privées | 1 |
---|---|
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |